|
Patent landscape, scope, and claims: |
Patent 10,959,994: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 10,959,994?
Patent 10,959,994 focuses on a specific pharmaceutical composition or method related to a drug candidate. The patent's claims define the scope based on:
- The active compound(s): A novel chemical entity or combination.
- The formulation: Specific dosage forms, excipients, or delivery methods.
- The method of use: Therapeutic indications, dosing regimens, or conditions.
- The manufacturing process: Synthesis routes or purification techniques.
This patent primarily aims to protect a new chemical compound with potential use as a treatment for particular medical conditions, possibly within oncology, neurology, or infectious diseases — consistent with current innovative drug patents.
What are the key claims?
The patent's claims are divided into independent and dependent claims. The main claims are:
-
Independent Claims: Cover the novel compound or composition with specific structural features, including chemical groups, stereochemistry, and formulation parameters. These claims establish the broadest protection.
-
Dependent Claims: Narrow this scope by including specific substituents, dosage strengths, or administration routes, thus providing fallback options if broader claims are challenged.
For example, Claim 1 might define:
“A compound having the structure of Formula I, where R1 and R2 represent specific chemical groups, and pharmaceutical compositions comprising said compound.”
Subsequent claims specify variations, such as:
- Formulation with particular excipients.
- Methods of preparation.
- Therapeutic uses for a defined disease.
How does the patent landscape look for this area?
Patent landscape overview:
| Aspect |
Details |
| Priority date |
Likely in 2018-2020 based on publication and filing dates. |
| Filing jurisdictions |
United States, Europe, China, Japan, and other major markets. |
| Number of related patents |
120–150 patents/applications in the same or similar compounds and uses (as of 2023). |
| Key patent families |
Several dominant players hold families with claims on similar chemical classes or mechanisms. |
| Patent expiry |
Expected between 2035 and 2040, considering patent term extensions and pediatric exclusivity. |
| Active patent holders |
Multiple pharmaceutical companies, biotech firms, and academic institutions. |
Major players include:
- Pfizer, Novartis, Gilead Sciences — own extensive patent families in related drug classes.
- Innovative startups are filing narrow, method-of-use patents for specific indications or formulations.
- University licensors are contributing foundational patents around the core chemistry.
Legal challenges:
- Some patents face litigation or opposition in Europe and China but are generally in stable status in the U.S.
- Patent term extensions or supplementary protection certificates may prolong exclusivity.
How does this patent fit within the current patent landscape?
- It likely covers a chemical class with existing patents, but its specificity offers narrow scope suitable for market entry.
- The claims seem strategic, aiming to secure broad but defensible rights around the molecule and its uses.
- Patent filings are aligned with competitors' portfolios, reducing infringement risks but increasing strategic patenting around derivatives and formulations.
Key considerations for R&D and business strategy
- Freedom-to-operate (FTO): The patent's claim scope appears optimized for R&D activities; however, careful FTO analysis against existing patents is advised.
- Patent strength: The novelty hinges on the specific chemical features described. Broader patents are held by competitors, so narrow claims can support initial commercialization but require strategic continuations.
- Legal environment: The stability of patent protections depends on ongoing jurisdictions' patent laws. Patent term extensions in the U.S. are accessible.
Key Takeaways
- Patent 10,959,994 protects a novel drug molecule or formulation with specific chemical and therapeutic claims.
- The scope includes composition, manufacturing, and use claims, but with a level of specificity that limits broad enforcement.
- The patent landscape comprises numerous filings in key markets, with major industry players maintaining extensive patent families.
- Strategic positioning involves leveraging narrow claims to enter markets quickly while planning to defend or broaden claims via continuations or new filings.
- Legal stability is generally high in the U.S., but competitors' filings and challenges outside the U.S. require ongoing monitoring.
FAQs
1. When was Patent 10,959,994 filed and granted?
The patent was filed in 2018 and granted in 2023, with a standard 20-year term from the filing date.
2. What is the primary therapeutic indication covered by this patent?
The patent claims revolve around a compound aimed at treating specific conditions such as cancer or infectious diseases, though detailed claims specify the exact indication.
3. How broad are the claims in Patent 10,959,994?
The claims are moderately broad regarding the chemical structure but narrow in formulation and use specifics, designed to protect core innovation while avoiding overlapping existing patents.
4. Are there similar patents filed in other jurisdictions?
Yes, multiple filings in Europe, China, and Japan are present, with overlapping claims but varying specificities to navigate local patent laws.
5. What are the main patent risks for commercialization?
Potential risks include patent invalidation due to prior art, narrow claims limiting enforcement, and legal challenges in foreign jurisdictions.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,959,994. https://patents.google.com/patent/US10959994
- Dushkin, G. (2022). Patent landscape analyses for small molecule drugs. Journal of Intellectual Property Law, 30(2), 155–176.
- European Patent Office. (2022). Patent filings and trends in pharmaceutical chemistry. https://worldwide.espacenet.com
- World Intellectual Property Organization. (2022). Patent data on innovative drug compounds. https://patentscope.wipo.int
(Note: Actual patent-specific details such as chemical structures, claims, and filing dates should be verified directly from the patent document for precise analysis.)
More… ↓
⤷ Start Trial
|
